Policy changes Backwork has recorded, newest first. The most recent change on record is from October 24, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
86,510 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Somatic Biomarker Testing for Immune Checkpoint Inhibitor Therapy (BRAF, MSI/MMR, PD-L1, TMB) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Somatic Biomarker Testing (Including Liquid Biopsy) for Targeted Treatment in Non-Small-Cell Lung Cancer (EGFR, ALK, BRAF, ROS1, RET, MET, KRAS, NTRK) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Somatic Biomarker Testing (Including Liquid Biopsy) for Targeted Treatment in Metastatic Colorectal Cancer (KRAS, NRAS, BRAF, and HER2) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Solaraze 3% (diclofenac) Gel | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Small Bowel/Liver and Multivisceral Transplant | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Sleep Disorders | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Skin Contact Monochromatic Infrared Energy as a Technique to Treat Cutaneous Ulcers, Diabetic Neuropathy and Miscellaneous Musculoskeletal Conditions | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Signal-Averaged Electrocardiography (ECG)(SAECG) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Serum Holo-Transcobalamin as a Marker of Vitamin B12 (i.e., Cobalamin) Status | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Serum Biomarker Tests for Multiple Sclerosis | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Serum Biomarker Panel Testing for Systemic Lupus Erythematosus and Other Connective Tissue Diseases | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Serum Biomarker Human Epididymis Protein 4 (HE4) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Serologic Testing for Helicobacter Pylori | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Serologic Genetic and Molecular Screening for Colorectal Cancer | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Serologic Diagnosis of Celiac Disease | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Sensory Stimulation for Coma Patients | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Sensory Integration Therapy and Auditory Integration Therapy | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Semi-Implantable and Fully Implantable Middle Ear Hearing Aids | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Selected Positron Emission Tomography Technologies for Evaluation of Alzheimer Disease | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Screening Services and Procedures | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Screening for Lung Cancer Using Computed Tomography (CT) Scanning | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Scintimammography and Gamma Imaging of the Breast and Axilla | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Scenesse (afamelanotide) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Savella (milnacipran) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Saturation Biopsy for Diagnosis, Staging, and Management of Prostate Cancer | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Sacral Nerve Neuromodulation/Stimulation | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Ryzneuta (efbemalenograstim alfa-vuxw) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Ryoncil (remestemcel-L-rknd) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Rolvedon (eflapegrastim-xnst) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Rituximab Non-Oncology | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Risk-Reducing Medications for Primary Breast Cancer | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Risk-Reducing Mastectomy | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Rhinoplasty | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Reyvow (lasmiditan) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Revcovi (elapegademase-lvlr) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Retinal Telescreening for Diabetic Retinopathy | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Retinal Prosthesis | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Responsive Neurostimulation for the Treatment of Refractory Focal Epilepsy | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Respiratory Devices | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Renal Denervation for Uncontrolled Hypertension | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Removal of Benign Skin Lesions and Scars | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Remote Electrical Neuromodulation for Migraines | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Reduction Mammoplasty | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Recarbrio (imipenem-cilastatin-relebactam) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Reblozyl (luspatercept-aamt) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Real-Time Intra-Fraction Motion Management During Radiation Therapy | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Radioimmunotherapy in the Treatment of Non-Hodgkin Lymphoma | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Radioimmunoscintigraphy (Monoclonal Antibody Imaging) With Indium 111 Capromab Pendetide for Prostate Cancer | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Radiofrequency Volumetric Tissue Reduction for Nasal Obstruction | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Radiofrequency Coblation Tenotomy for Musculoskeletal Conditions | New policy |